These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15927309)

  • 1. 3,4-trans-4-Aryl-3-(1-pyridinio)-1,2,3,4-tetrahydropyridine-6-thiolates--new group of potential cardiotonic drugs.
    Krauze A; Vītoliņa R; Garaliene V; Sīle L; Klusa V; Duburs G
    Eur J Med Chem; 2005 Nov; 40(11):1163-7. PubMed ID: 15927309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents.
    Bekhit AA; Baraka AM
    Eur J Med Chem; 2005 Dec; 40(12):1405-13. PubMed ID: 16040161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
    Hagen V; Hagen A; Krause EG; Klauschenz E
    Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo cardiotonic activity of pyridylmethylene-2-indolinones.
    Andreani A; Locatelli A; Morigi R; Leoni A; Bossa R; Chiericozzi M; Galatulas I
    Arzneimittelforschung; 1998 Jul; 48(7):727-9. PubMed ID: 9706372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
    Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
    Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
    Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters.
    Mosti L; Menozzi G; Schenone P; Dorigo P; Gaion RM; Belluco P
    Farmaco; 1992 Apr; 47(4):427-37. PubMed ID: 1388591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.
    Dorigo P; Fraccarollo D; Santostasi G; Maragno I; Floreani M; Borea PA; Mosti L; Sansebastiano L; Fossa P; Orsini F; Benetollo F; Bombieri G
    J Med Chem; 1996 Sep; 39(19):3671-83. PubMed ID: 8809156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential cardiotonic agents. 11. Synthesis and cardiovascular effects of 5-alkyl-substituted 2-amino-3-cyano-5- -4-dyl)pyridines].
    Klauschenz E; Hagen V; Hagen A; Heer S
    Pharmazie; 1990 Jul; 45(8):628. PubMed ID: 2080215
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
    Heber D; Ravens U; Schulze T
    Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo cardiotonic activity of aryl- and pyridyl-substituted fused imidazoles.
    Andreani A; Leoni A; Morigi R; Bossa R; Chiericozzi M; Galatulas I
    Arzneimittelforschung; 1998 Mar; 48(3):232-5. PubMed ID: 9553678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazo[1,2-alpha]pyridines. II. Ozonolysis of imidazo[1,2-alpha]pyridines and synthesis of cardiotonic agents.
    Yamanaka M; Suda S; Yoneda N; Ohhara H
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):666-74. PubMed ID: 1611679
    [No Abstract]   [Full Text] [Related]  

  • 16. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
    Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
    Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and cardiotonic activity of pyrazolylpyrimidines].
    Sedereviciute V; Garaliene V; Vainilavicius P; Hetzheim A
    Pharmazie; 1998 Apr; 53(4):233-7. PubMed ID: 9583084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and positive inotropic action of some 5-substituted 5H-(1)benzopyrano(4,3-b)pyridines].
    Heber D; Ravens U
    Arzneimittelforschung; 1985; 35(11):1624-6. PubMed ID: 4091865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-aralkyl substitution of 2-aminoindans. Synthesis and their inotropic and chronotropic activity in isolated guinea pig atria.
    Pérez JA; Domínguez JN; Angel JE; Duerto de Pérez Z; Salazar-Bookaman MM; Acosta H; Charris JE
    Arzneimittelforschung; 1997 Nov; 47(11):1208-10. PubMed ID: 9428975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA; Marsh KC; Polakowski JS; Fryer RM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.